|
LOC285359 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.436800E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.161200E-03 |
| Normal-vs-Stage2 |
1.193750E-01 |
| Normal-vs-Stage3 |
4.806800E-01 |
| Normal-vs-Stage4 |
4.962200E-01 |
| Stage1-vs-Stage2 |
9.200600E-01 |
| Stage1-vs-Stage3 |
1.500400E-01 |
| Stage1-vs-Stage4 |
9.826200E-01 |
| Stage2-vs-Stage3 |
3.732200E-01 |
| Stage2-vs-Stage4 |
9.882600E-01 |
| Stage3-vs-Stage4 |
6.698800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.188200E-04 |
| Normal-vs-AfricanAmerican |
4.811700E-02 |
| Normal-vs-Asian |
9.280500E-02 |
| Caucasian-vs-AfricanAmerican |
8.712100E-02 |
| Caucasian-vs-Asian |
9.375000E-01 |
| AfricanAmerican-vs-Asian |
5.768800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.155000E-04 |
| Normal-vs-Female |
5.583800E-02 |
| Male-vs-Female |
9.794300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.330200E-02 |
| Normal-vs-Extreme_Weight |
8.395900E-03 |
| Normal-vs-Obese |
6.002600E-03 |
| Normal-vs-Extreme_Obese |
2.427900E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.993200E-01 |
| Normal_Weight-vs-Obese |
7.755200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.372000E-01 |
| Extreme_Weight-vs-Obese |
7.212400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.937200E-01 |
| Obese-vs-Extreme_Obese |
8.448000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.488460E-02 |
| Normal-vs-Age(41-60Yrs) |
2.196800E-04 |
| Normal-vs-Age(61-80Yrs) |
5.103800E-03 |
| Normal-vs-Age(81-100Yrs) |
7.787600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.067000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.433800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.424410E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.391400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.818100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.559600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.84519999946176E-07 |
| Normal-VS-Type2 PRCC |
9.999000E-01 |
| Normal-VS-KIRP CIMP |
3.871000E-01 |
| Normal-VS-Unclassified PRCC |
2.421200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.52020000032671E-07 |
| Type1 PRCC-VS-KIRP CIMP |
3.578900E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.576400E-03 |
| Type2 PRCC-VS-KIRP CIMP |
5.504800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.764600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.584180E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.665900E-02 |
| Normal-vs-N1 |
1.310250E-01 |
| Normal-vs-N2 |
1.118250E-01 |
| N0-vs-N1 |
5.769000E-01 |
| N0-vs-N2 |
7.604000E-02 |
| N1-vs-N2 |
6.864300E-03 |
|
|
